Back to Market Feed

Product Information

ALOGLIPTIN 12.5 MG TABLET is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $5.0543 per EA under NDC 45802010365. Its NADAC has been published 492 times since Mar 22, 2017.

FDA first approved this application on Jan 25, 2013.

ALOGLIPTIN 12.5 MG TABLET

Alogliptin
$5.0543per EA

Strength

12.5 mg/1

NDC

45802010365

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ALOGLIPTIN BENZOATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA022271

FDA Approved

1/25/2013

On Market Since

4/8/2016

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price Statistics

The NADAC for ALOGLIPTIN 12.5 MG TABLET has been published 492 times since Mar 22, 2017, and over the history we have for it it has declined 12.9%. The table below summarizes its recorded NADAC range and movement.

Current price$5.0543 per EA
All-time high$6.1823 (Feb 14, 2018)
All-time low$4.2188 (Jul 17, 2024)
52-week high$5.0543
52-week low$4.5420
Median price$5.2540
Average price$5.2948
Largest weekly change-15.0% (Mar 20, 2019)
Weeks tracked492
Tracking sinceMar 22, 2017

Price History

1W

+0.1%

1M

+0.1%

3M

+6.1%

6M

+8.5%

1Y

+10.5%

3Y

+0.9%

5Y

-0.8%

All

-12.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Alogliptin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

SAXAGLIPTIN HCL 5 MG TABLET
Generic
00378470677•Mylan Pharmaceuticals Inc.
$1.0495
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
00378470693•Mylan Pharmaceuticals Inc.
$1.0495
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
65862082630•Aurobindo Pharma Limited
$1.0495
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
65862082690•Aurobindo Pharma Limited
$1.0495
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
68462072730•Glenmark Pharmaceuticals Inc., USA
$1.0495
per EA
SAXAGLIPTIN HCL 5 MG TABLET
Generic
68462072790•Glenmark Pharmaceuticals Inc., USA
$1.0495
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
00378470577•Mylan Pharmaceuticals Inc.
$1.1405
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
00378470593•Mylan Pharmaceuticals Inc.
$1.1405
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
65862082530•Aurobindo Pharma Limited
$1.1405
per EA
SAXAGLIPTIN HCL 2.5 MG TABLET
Generic
65862082590•Aurobindo Pharma Limited
$1.1405
per EA

Frequently asked questions

What is the NADAC price of ALOGLIPTIN 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ALOGLIPTIN 12.5 MG TABLET, manufactured by Padagis Israel Pharmaceuticals Ltd, is $5.0543 per EA (NDC 45802010365), effective Aug 19, 2026.

How has the price of ALOGLIPTIN 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ALOGLIPTIN 12.5 MG TABLET has declined 12.9%. It has been tracked across 492 weekly CMS publications since Mar 22, 2017.

What are the highest and lowest recorded NADAC prices for ALOGLIPTIN 12.5 MG TABLET?

Since Mar 22, 2017, the NADAC for ALOGLIPTIN 12.5 MG TABLET has ranged from a low of $4.2188 (Jul 17, 2024) to a high of $6.1823 (Feb 14, 2018), with a median of $5.2540 per EA.

Are there cheaper alternatives to ALOGLIPTIN 12.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ALOGLIPTIN 12.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ALOGLIPTIN 12.5 MG TABLET?

ALOGLIPTIN 12.5 MG TABLET (NDC 45802010365) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.